Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

3 results about "Hormone sensitivity" patented technology

Hormone-sensitive lipase (EC 3.1.1.79, HSL), also previously known as cholesteryl ester hydrolase (CEH), is an enzyme that, in humans, is encoded by the LIPE gene. HSL is an intracellular neutral lipase that is capable of hydrolyzing a variety of esters. The enzyme has a long and a short form.

Plant growth elicitor dose regulation method and system based on sample analysis

PendingCN122307040ABiotechnologyGrowth plant
This invention relates to the field of inducible hormone dosage regulation, and more particularly to a method and system for regulating plant growth inducible hormone dosage based on sample analysis. The method includes the following steps: collecting rice samples from multiple cultivation environments, monitoring photosynthesis to obtain response sequences over multiple periods; eliminating inefficient samples based on the response sequences to obtain response curves for candidate samples; identifying growth stages from the response curves of the candidate samples to obtain growth stage curves; performing inducible hormone gain analysis based on the growth stage curves to obtain inducible hormone sensitivity values ​​for different samples; and iteratively calculating and risk-screening the inducible hormone combination ratio based on the inducible hormone sensitivity values ​​of different samples to output the optimal dosage ratio. This invention improves the photosynthetic efficiency and enhances growth stability of rice.
Owner:WEIFANG AOFENG CROP DISEASE CONTROL CO LTD

System and method for carrying out auxiliary analysis on hormone-sensitive chronic cough

The invention relates to the technical field of data processing, in particular to a system and a method for auxiliary analysis of hormone-sensitive chronic cough, and the method comprises the following steps: collecting target indexes of a patient, including allergic disease history, sour regurgitation heartburn symptom, hematophilic granulocyte count, CRP, IgE, FEV1 / FVC and FeNO; preprocessing the target index to obtain a preprocessed index; and generating a risk score corresponding to the hormone-sensitive chronic cough according to the pretreatment index. In order to solve the problems that in the prior art, hormone-sensitive cough diagnosis indexes need to depend on a complex detection instrument to be collected, and implementation is difficult, on the basis of regression analysis, the indexes of auxiliary analysis are determined to be clinical data which can be obtained easily based on clinical symptoms, blood routine indexes, lung function examination and the like of a patient, and the hormone-sensitive cough diagnosis indexes are obtained. And a related auxiliary analysis system is established, so that complex instruments required in the traditional medical examination process are omitted, and the medical examination process can be quickly completed in any level of medical institutions.
Owner:SHANGHAI TONGJI HOSPITAL

Hormone sensitivity dynamic detection system based on endometrial cancer organs

The invention discloses a progestational hormone sensitivity dynamic detection system based on endometrial cancer organs. The progestational hormone sensitivity dynamic detection system comprises an organoid culture module, a progestational hormone detection module and a progestational hormone detection module, wherein the organoid culture module is used for culturing the endometrial cancer organs; and the progestational hormone stimulation module is used for conveying different concentrations and types of progestational hormones to different culture chambers in the organoid culture module. The invention relates to the technical field of medical detection. The progestational hormone sensitivity dynamic detection system based on the endometrial cancer organs can dynamically monitor biological changes of the endometrial cancer organs under stimulation of the progestational hormone in real time, capture early events and dynamic processes of response of cells to the progestational hormone, provide more comprehensive progestational hormone sensitivity information and improve the progestational hormone sensitivity detection accuracy. The system can provide individualized progestational hormone treatment schemes and prognosis prediction for endometrial cancer patients, the treatment effect is improved, invalid treatment is reduced, the medical cost and patient pain are reduced, and the system has important clinical application prospects.
Owner:NINGXIA MEDICAL UNIVERSITY GENERAL HOSPITAL